A phase I clinical trial of the sequential combination of irinotecan followed by flavopiridol.

Source:http://linkedlifedata.com/resource/pubmed/id/15897584

Clin. Cancer Res. 2005 May 15 11 10 3836-45

Download in:

View as

Triples

General Info

PMID
15897584